Literature DB >> 11123715

Skull base chordomas: correlation of tumour doubling time with age, mitosis and Ki67 proliferation index.

J L Holton1, T Steel, M Luxsuwong, H A Crockard, T Revesz.   

Abstract

The aim of the study was to assess the relationship between the rate of clinical tumour growth and various histological features, including Ki67 labelling index, in skull base chordoma. Cases of skull base chordoma from 19 patients (six female, 13 male; age range 8-63 years) were reviewed and the diagnosis confirmed based on histological and immunohistochemical features. In each biopsy cellularity, pleomorphism, mitotic activity, apoptotic bodies, necrosis and inflammatory cell infiltrate were graded and Ki67 labelling index (LI) calculated as a measure of proliferation. Tumour doubling time was assessed by quantitative analysis of tumour volumes in post-operative magnetic resonance images and correlated with age, sex, histological parameters and Ki67 LI. It was shown that increasing patient age, the presence of mitotic figures or a Ki67 LI in excess of 6% were associated with faster growing tumours.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123715     DOI: 10.1046/j.1365-2990.2000.00280.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  8 in total

Review 1.  Current therapeutic options and novel molecular markers in skull base chordomas.

Authors:  Filippo Gagliardi; Nicola Boari; Paola Riva; Pietro Mortini
Journal:  Neurosurg Rev       Date:  2011-10-18       Impact factor: 3.042

2.  The prognostic value of Ki-67, p53, epidermal growth factor receptor, 1p36, 9p21, 10q23, and 17p13 in skull base chordomas.

Authors:  Craig Horbinski; Gerard J Oakley; Kathleen Cieply; Geeta S Mantha; Marina N Nikiforova; Sanja Dacic; Raja R Seethala
Journal:  Arch Pathol Lab Med       Date:  2010-08       Impact factor: 5.534

3.  Surgery for chordomas of the craniocervical junction: lessons learned.

Authors:  David Choi; Michael Gleeson
Journal:  Skull Base       Date:  2010-01

4.  Analysis of variants at LGALS3 single nucleotide polymorphism loci in skull base chordoma.

Authors:  Kaibing Tian; Liang Wang; Ke Wang; Junpeng Ma; Da Li; Yang Yang; Guijun Jia; Zhen Wu; Liwei Zhang; Junting Zhang
Journal:  Oncol Lett       Date:  2018-05-22       Impact factor: 2.967

5.  Sacral chordoma in an adult showing an aggressive clinical course: A case report.

Authors:  Koji Endo; Hideki Yamashita; Hideki Nagashima; Ryota Teshima
Journal:  Oncol Lett       Date:  2014-02-19       Impact factor: 2.967

6.  Simultaneous discovery of cranial and spinal intradural chordomas: case report.

Authors:  Yoshifumi Kawanabe; Shigeo Ueda; Nobuhiro Sasaki; Minoru Hoshimaru
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-01-28       Impact factor: 1.742

7.  Factors for tumor progression in patients with skull base chordoma.

Authors:  Liang Wang; Kaibing Tian; Ke Wang; Junpeng Ma; Xiaojuan Ru; Jiang Du; Guijun Jia; Liwei Zhang; Zhen Wu; Junting Zhang
Journal:  Cancer Med       Date:  2016-08-21       Impact factor: 4.452

8.  Clinicopathological significance of p16, cyclin D1, Rb and MIB-1 levels in skull base chordoma and chondrosarcoma.

Authors:  Jun-Qi Liu; Qiu-Hang Zhang; Zhen-Lin Wang
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2015-10-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.